Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
filingDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb3fabd5b49d7b388392cb7a64cdcdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c035d3660825275c74c647331f0743c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3714d96db3fef3df68df0adfd634a7a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6840df5b4ba406a4c95e808b8da04a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031ebb2943255bc6cbb8629da2b6d2c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d001eb0d29e5ef74899ae3cb69812d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571d790e60f8c52da323e4d6997ae3f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834cd90451ae0e63fff003d33c8ed5ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebed0878fcc4a9b14cb73ca4fe82c0d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4838c7caf05760118ecd98d53b4b77a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfaf8872876c803b774c6d35a71eacb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9412de3f52a8670dec8deda5dee7d29 |
publicationDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20190016976-A |
titleOfInvention |
Azabenzimidazole derivatives as PI3K beta inhibitors |
abstract |
The present invention relates to compounds of formula (I) (I) ≪ / RTI > wherein the variables have the meanings as defined in the claims. The compounds according to the invention are useful as pI3K [beta] inhibitors. The invention further relates to a pharmaceutical composition comprising said compound as an active ingredient and to the use of said compound as a medicament. |
priorityDate |
2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |